Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

“Combining Illumina’s world-leading sequencing and analytics platforms with Nvidia’s accelerated computing and AI, we will drive the next generation of genomics interpretation and ...

“This is the same instrument the scientific community has come to rely on for next-generation sequencing, now with upgraded software, new kits, and the option for a lower volume,” Illumina’s ...

SAN DIEGO, Jan. 13, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology ...

Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...

A modernized ART for Illumina read simulation.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms and make Nvidia’s BioNeMo tools available on the next-gen sequencing giant’s Illumina Connected ...